Figure 14
Binding interaction of most active compounds 4i, 4 m, 4n and Erlotinib then superimposed in active site to validate the docking protocol.
Figure 14 | Scientific Reports
Binding interaction of most active compounds 4i, 4 m, 4n and Erlotinib then superimposed in active site to validate the docking protocol.
